Genomics

Oxford, United Kingdom · Founded 2014 · Privately Held (backing)

Developer of a genetic inference technology designed to lead the genomic transformation by finding new drug targets for serious diseases. Genomics is based in Oxford, United Kingdom and was founded in 2014. Its last known valuation is $162 million. It has raised $142 million.

Last price · $/share
—
Implied valuation
$161.6M
Total raised
$142.2M
Last round
—

Who backs Genomics?

16 investors
InvestorType
F-Prime CapitalVenture capital
Eight RoadsAsset manager
Salica InvestmentsVenture capital
University of Oxford—
Oxford Science EnterprisesVenture capital
Foresite CapitalVenture capital
Lansdowne PartnersHedge fund
Woodford Investment ManagementOther
Tanarra CapitalOther
University of Oxford EndowmentOther
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Genomics investors

16 investors are on record for Genomics, including F-Prime Capital, Eight Roads, Salica Investments and University of Oxford. By type, the record holds 4 venture capital firms and 2 hedge funds.

Free account
More of Genomics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Genomics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Genomics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View